Uterine NK cells regulate endometrial bleeding in women and are suppressed by the progesterone receptor modulator asoprisnil

Journal of Immunology

Volumn 191, Issue 5, 2013, Pages 2226-2235

  Wilkens, Julia ^a   Male, Victoria ^b,f   Ghazal, Peter ^c   Forster, Thorsten ^c   Gibson, Douglas A ^a   Williams, Alistair R W ^a   Brito Mutunayagam, Savita L ^a   Craigon, Marie ^c   Lourenco, Paula ^a   Cameron, Iain T ^d   Chwalisz, Kristof ^e   Moffett, Ashley ^b   Critchley, Hilary O D ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e ABBOTT LABORATORIES   (United States)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASOPRISNIL; CD56 ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; MESSENGER RNA; PLACEBO; PROGESTERONE RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG RECEPTOR BINDING; DRUG TARGETING; ENDOMETRIAL BLEEDING; ENDOMETRIAL DISEASE; ENDOMETRIUM BLEEDING; FEMALE; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IL 15 GENE; IL 15RA GENE; IMMUNOHISTOCHEMISTRY; MULTICENTER STUDY; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; STROMA CELL;

DOUBLE-BLIND METHOD; ENDOMETRIUM; ESTRENES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-15; KILLER CELLS, NATURAL; LEIOMYOMA; LYMPHOCYTE ACTIVATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIMES; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTOME; UTERINE NEOPLASMS; UTERUS;

EID: 84883383229     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300958     Document Type: Article

References (48)

1. King, A., N. Balendran, P. Wooding, N. P. Carter, and Y. W. Loke. 1991. CD3-leukocytes present in the human uterus during early placentation: phenotypic and morphologic characterization of the CD56++ population. Dev. Immunol. 1: 169-190.
2. Hanna, J., D. Goldman-Wohl, Y. Hamani, I. Avraham, C. Greenfield, S. Natanson-Yaron, D. Prus, L. Cohen-Daniel, T. I. Arnon, I. Manaster, et al. 2006. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 12: 1065-1074.
3. Hiby, S. E., J. J. Walker, K. M. O'Shaughnessy, C. W. Redman, M. Carrington, J. Trowsdale, and A. Moffett. 2004. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200: 957-965.
4. Robson, A., L. K. Harris, B. A. Innes, G. E. Lash, M. M. Aljunaidy, J. D. Aplin, P. N. Baker, S. C. Robson, and J. N. Bulmer. 2012. Uterine natural killer cells initiate spiral artery remodeling in human pregnancy. FASEB J. 26: 4876-4885.
5. King, A., V. Wellings, L. Gardner, and Y. W. Loke. 1989. Immunocytochemical characterization of the unusual large granular lymphocytes in human endometrium throughout the menstrual cycle. Hum. Immunol. 24: 195-205.
6. Pace, D., L. Morrison, and J. N. Bulmer. 1989. Proliferative activity in endometrial stromal granulocytes throughout menstrual cycle and early pregnancy. J. Clin. Pathol. 42: 35-39.
7. Moffett-King, A. 2002. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2: 656-663.
8. Li, X. F., D. S. Charnock-Jones, E. Zhang, S. Hiby, S. Malik, K. Day, D. Licence, J. M. Bowen, L. Gardner, A. King, et al. 2001. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J. Clin. Endocrinol. Metab. 86: 1823-1834.
9. Lash, G. E., B. Schiessl, M. Kirkley, B. A. Innes, A. Cooper, R. F. Searle, S. C. Robson, and J. N. Bulmer. 2006. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J. Leukoc. Biol. 80: 572-580.
10. Vacca, P., C. Cantoni, C. Prato, E. Fulcheri, A. Moretta, L. Moretta, and M. C. Mingari. 2008. Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells. Int. Immunol. 20: 1395-1405.
11. Cardozo, E. R., A. D. Clark, N. K. Banks, M. B. Henne, B. J. Stegmann, and J. H. Segars. 2012. The estimated annual cost of uterine leiomyomata in the United States. Am. J. Obstet. Gynecol. 206: 211.e1-9.
12. National Collaborating Centre for Women's and Children's Health. 2007. Clinical Guideline 44. Heavy menstrual bleeding. http://www.nice.org.uk/ nicemedia/pdf/CG44FullGuideline.pdf.
13. Chabbert-Buffet, N., G. Meduri, P. Bouchard, and I. M. Spitz. 2005. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. Hum. Reprod. Update 11: 293-307.
14. Wilkens, J., K. Chwalisz, C. Han, J. Walker, I. T. Cameron, S. Ingamells, A. C. Lawrence, M. A. Lumsden, D. Hapangama, A. R. Williams, and H. O. Critchley. 2008. Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy. J. Clin. Endocrinol. Metab. 93: 4664-4671.
15. Chwalisz, K., M. C. Perez, D. Demanno, C. Winkel, G. Schubert, and W. Elger. 2005. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. Endocr. Rev. 26: 423-438.
16. Chwalisz, K., W. Elger, T. Stickler, C. Mattia-Goldberg, and L. Larsen. 2005. The effects of 1-month administration of asoprisnil (J867), a selective progesterone receptor modulator, in healthy premenopausal women. Hum. Reprod. 20: 1090-1099.
17. Williams, A. R., H. O. Critchley, J. Osei, S. Ingamells, I. T. Cameron, C. Han, and K. Chwalisz. 2007. The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata. Hum. Reprod. 22: 1696-1704.
18. Brenner, R. M., and O. D. Slayden. 2004. Steroid receptors in blood vessels of the rhesus macaque endometrium: a review. Arch. Histol. Cytol. 67: 411-416.
19. Critchley, H. O., R. M. Brenner, T. A. Henderson, K. Williams, N. R. Nayak, O. D. Slayden, M. R. Millar, and P. T. Saunders. 2001. Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium. J. Clin. Endocrinol. Metab. 86: 1370-1378.
20. Henderson, T. A., P. T. Saunders, A. Moffett-King, N. P. Groome, and H. O. Critchley. 2003. Steroid receptor expression in uterine natural killer cells. J. Clin. Endocrinol. Metab. 88: 440-449.
21. Barber, E. M., and J. W. Pollard. 2003. The uterine NK cell population requires IL-15 but these cells are not required for pregnancy nor the resolution of a Listeria monocytogenes infection. J. Immunol. 171: 37-46.
22. Kitaya, K., T. Yamaguchi, and H. Honjo. 2005. Central role of interleukin-15 in postovulatory recruitment of peripheral blood CD16(-) natural killer cells into human endometrium. J. Clin. Endocrinol. Metab. 90: 2932-2940.
23. Male, V., A. Sharkey, L. Masters, P. R. Kennedy, L. E. Farrell, and A.Moffett. 2011. The effect of pregnancy on the uterine NK cell KIR repertoire. Eur. J. Immunol. 41: 3017-3027.
24. Male, V., A. Trundley, L. Gardner, J. Northfield, C. Chang, R. Apps, and A. Moffett. 2010. Natural killer cells in human pregnancy. Methods Mol. Biol. 612: 447-463.
25. Benjamini, Y., and D. Yekutieli. 2001. The control of the false discovery rate in multiple testing under dependency. Ann. Statist. 29: 1165-1188.
26. Edgar, R., M. Domrachev, and A. E. Lash. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30: 207-210.
27. Wilkens, J., A. R. Williams, K. Chwalisz, C. Han, I. T. Cameron, and H. O. Critchley. 2009. Effect of asoprisnil on uterine proliferation markers and endometrial expression of the tumour suppressor gene, PTEN. Hum. Reprod. 24: 1036-1044.
28. Shaw, J. L., F. C. Denison, J. Evans, K. Durno, A. R. Williams, G. Entrican, H. O. Critchley, H. N. Jabbour, and A. W. Horne. 2010. Evidence of prokineticin dysregulation in fallopian tube from women with ectopic pregnancy. Fertil. Steril. 94: 1601-1608.e1601.
29. Bancroft, J., and A. Stevens. 1996. Theory and Practice of Histological Techniques. Churchill Livingstone, Edinburgh.
30. Verma, S., S. E. Hiby, Y. W. Loke, and A. King. 2000. Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol. Reprod. 62: 959-968.
31. Kitaya, K., J. Yasuda, I. Yagi, Y. Tada, S. Fushiki, and H. Honjo. 2000. IL-15 expression at human endometrium and decidua. Biol. Reprod. 63: 683-687.
32. Dunn, C. L., H. O. Critchley, and R. W. Kelly. 2002. IL-15 regulation in human endometrial stromal cells. J. Clin. Endocrinol. Metab. 87: 1898-1901.
33. Dubois, S., H. J. Patel, M. Zhang, T. A. Waldmann, and J. R. Müller. 2008. Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action. J. Immunol. 180: 2099-2106.
34. Wu, Z., and Y. Xu. 2010. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation. J. Mol. Cell Biol. 2: 217-222.
35. Male, V., T. Hughes, S. McClory, F. Colucci, M. A. Caligiuri, and A. Moffett. 2010. Immature NK cells, capable of producing IL-22, are present in human uterine mucosa. J. Immunol. 185: 3913-3918.
36. Okada, H., T. Nakajima, M. Sanezumi, A. Ikuta, K. Yasuda, and H. Kanzaki. 2000. Progesterone enhances interleukin-15 production in human endometrial stromal cells in vitro. J. Clin. Endocrinol. Metab. 85: 4765-4770.
37. Croy, B. A., S. Esadeg, S. Chantakru, M. van den Heuvel, V. A. Paffaro, H. He, G. P. Black, A. A. Ashkar, Y. Kiso, and J. Zhang. 2003. Update on pathways regulating the activation of uterine Natural Killer cells, their interactions with decidual spiral arteries and homing of their precursors to the uterus. J. Reprod. Immunol. 59: 175-191.
38. Ashkar, A. A., G. P. Black, Q. Wei, H. He, L. Liang, J. R. Head, and B. A. Croy. 2003. Assessment of requirements for IL-15 and IFN regulatory factors in uterine NK cell differentiation and function during pregnancy. J. Immunol. 171: 2937-2944.
39. Mortier, E., T. Woo, R. Advincula, S. Gozalo, and A. Ma. 2008. IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J. Exp. Med. 205: 1213-1225.
40. King, A., L. Gardner, and Y. W. Loke. 1996. Evaluation of oestrogen and progesterone receptor expression in uterine mucosal lymphocytes. Hum. Reprod. 11: 1079-1082.
41. Stewart, J. A., J. N. Bulmer, and A. P. Murdoch. 1998. Endometrial leucocytes: expression of steroid hormone receptors. J. Clin. Pathol. 51: 121-126.
42. Milne, S. A., T. A. Henderson, R. W. Kelly, P. T. Saunders, D. T. Baird, and H. O. Critchley. 2005. Leukocyte populations and steroid receptor expression in human first-trimester decidua; regulation by antiprogestin and prostaglandin E analog. J. Clin. Endocrinol. Metab. 90: 4315-4321.
43. Trundley, A., and A. Moffett. 2004. Human uterine leukocytes and pregnancy. Tissue Antigens 63: 1-12.
44. Chakraborty, D., M. A. Rumi, T. Konno, and M. J. Soares. 2011. Natural killer cells direct hemochorial placentation by regulating hypoxia-inducible factor dependent trophoblast lineage decisions. Proc. Natl. Acad. Sci. USA 108: 16295-16300.
45. Williams, A. R., C. Bergeron, D. H. Barlow, and A. Ferenczy. 2012. Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate. Int. J. Gynecol. Pathol. 31: 556-569.
46. Ioffe, O. B., R. J. Zaino, and G. L. Mutter. 2009. Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator. Mod. Pathol. 22: 450-459.
47. Kam, E. P., L. Gardner, Y. W. Loke, and A. King. 1999. The role of trophoblast in the physiological change in decidual spiral arteries. Hum. Reprod. 14: 2131-2138.
48. Hickey, M., J. Crewe, J. P. Goodridge, C. S. Witt, I. S. Fraser, D. Doherty, F. T. Christiansen, and L. A. Salamonsen. 2005. Menopausal hormone therapy and irregular endometrial bleeding: a potential role for uterine natural killer cells? J. Clin. Endocrinol. Metab. 90: 5528-5535.